A systematic literature review and meta-analyses (where appropriate) were performed to
update the previous AASM practice parameters on the treatments, both dopaminergic and …

Although there has been progress in understanding, diagnosing and treating RLS, it
remains an underdiagnosed and undertreated condition severely impairing functioning of …

Background Restless legs syndrome (RLS) is a chronic disorder with substantial impact on
quality of life similar to that seen in diabetes mellitus or osteoarthritis. Little is known about …

There is growing awareness of impulsive‐compulsive spectrum behaviors (ICBs) in patients
with Parkinson's disease (PD) treated with dopamine replacement therapy (DRT). These …

The compulsive use of dopamine replacement therapy (DRT) or dopamine dysregulation
syndrome (DDS) is one of the behavioural disturbances reported in some patients with …

Augmentation syndrome is one of the most severe complications of RLS. It is characterised
by a worsening of treated symptoms; principally an increase in the severity of symptoms and …

AIM To investigate the association between restless legs syndrome (RLS) and well-defined
chronic liver disease, and the possible therapeutic options. METHODS Two hundred and …

Background: Restless legs syndrome (RLS) is a movement disorder treated with dopamine
agonists. RLS is often diagnosed as a comorbid condition with psychiatric disorders, which …

Study Objectives: Published literature documents increased risk for psychiatric adverse
events (P-AEs) following dopamine agonist (DA) initiation for treatment of primary restless …

Restless legs syndrome is a neurologic movement and sleep disorder with lifelong
symptoms causing considerable morbidity. Several short‐term and some long‐term open …